GSA Capital Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $982K | Buy |
|
|||||
|
2025
Q1 | $314K | Buy |
|
|||||
|
2024
Q4 | $490K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $198K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $247K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.09M | Sell |
|
|||||
|
2018
Q4 | $2.13M | Buy |
|
|||||
|
2018
Q3 | $1.86M | Sell |
|
|||||
|
2018
Q2 | $3.58M | Sell |
|
|||||
|
2018
Q1 | $5.45M | Buy |
|
|||||
|
2017
Q4 | $3.83M | Buy |
|
|||||
|
2017
Q3 | $558K | Sell |
|
|||||
|
2017
Q2 | $949K | Sell |
|
|||||
|
2017
Q1 | $2.84M | Buy |
|
|||||
|
2016
Q4 | $3.13M | Sell |
|
|||||
|
2016
Q3 | $3.89M | Buy |
|
|||||
|
2016
Q2 | $2.56M | Sell |
|
|||||
|
2016
Q1 | $4.82M | Sell |
|
|||||
|
2015
Q4 | $5.7M | Buy |
|
|||||
|
2015
Q3 | $3.58M | Buy |
|
|||||
|
2015
Q2 | $3.93M | Sell |
|
|||||
|
2015
Q1 | $3.72M | Buy |
|
|||||
|
2014
Q4 | $2.81M | Sell |
|
|||||
|
2014
Q3 | $2.27M | Buy |
|
|||||
|
2014
Q2 | $1.87M | Buy |
|
|||||
|
2014
Q1 | $1.65M | Buy |
|
|||||
|
2013
Q4 | $1.41M | Sell |
|
|||||
|
2013
Q3 | $1.27M | Buy |
|
|||||
|
2013
Q2 | $706K | Buy |
|